Cargando…
Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression
Current chemotherapy regimens have certain limitations in improving the survival rates of patients with advanced ovarian cancer. Hepatocyte growth factor (HGF) is important in ovarian cancer cell migration and invasion. This study assessed the effects of YYB-101, a humanized monoclonal anti-HGF anti...
Autores principales: | Kim, Hyun Jung, Lee, Sukmook, Oh, Yong-Seok, Chang, Ha Kyun, Kim, Young Sang, Hong, Sung Hee, Kim, Jung Yong, Park, Young-Whan, Lee, Song-Jae, Song, Seong-Won, Kim, Jung Ju, Heo, Kyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631954/ https://www.ncbi.nlm.nih.gov/pubmed/31355133 http://dx.doi.org/10.3389/fonc.2019.00571 |
Ejemplares similares
-
First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients
por: Kim, Seung Tae, et al.
Publicado: (2020) -
TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy
por: Heo, Kyun, et al.
Publicado: (2020) -
Gentian Violet Inhibits Cell Proliferation through Induction of Apoptosis in Ovarian Cancer Cells
por: Choi, Min Sung, et al.
Publicado: (2023) -
Catecholamines Promote Ovarian Cancer Progression through Secretion of CXC-Chemokines
por: Kim, Hyun Jung, et al.
Publicado: (2023) -
Perioperative Concerns and Complaints of Patients Undergoing Total Hip Arthroplasty
por: Park, Jung-Wee, et al.
Publicado: (2023)